Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Catheter-Associated Upper Extremity DVT in Cancer
NCT01708850Phase 4Completed
- Sponsor
- London Health Sciences Centre
- Start
- Nov 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban in catheter-related thrombosis (CRT), sponsored by London Health Sciences Centre. Primary endpoint: Proportion of central line failure at 12 weeks. Started Nov 2012; status: completed.
02
Drugs
rivaroxaban
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT01708850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708850.